Alembic Pharmaceuticals Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Alembic Pharmaceuticals Limited's balance sheet done over the years? Its assets were worth $64,455,800,000 last year, which is less than in the previous period. 25% of Alembic Pharmaceuticals Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $16,273,800,000, which means an decrease by -14% compared compared to last year.
Debt to Assets
| 2011 | 8436482000 | 5.48B | 65% |
|---|---|---|---|
| 2012 | 10519041000 | 6.56B | 62.45% |
| 2015 | 16411675000 | 7.56B | 46.1% |
| 2016 | 24593802000 | 8.58B | 34.92% |
| 2018 | 39410500000 | 17.20B | 43.66% |
| 2019 | 47777600000 | 20.59B | 43.11% |
| 2020 | 59890500000 | 27.98B | 46.73% |
| 2021 | 67089800000 | 16.42B | 24.47% |
| 2022 | 71220300000 | 18.84B | 26.46% |
| 2024 | 64455800000 | 16.27B | 25.25% |
APLLTD.NS Balance Sheet (2011 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 1.20B | 610.9M | 980.6M | 718.4M | 1.99B | 837.5M | 4.50B | 268.25M | 470.80M | 62.89M |
Short term investments | 0 | 316.2M | 1.86B | 0 | 0 | 121.8M | -846.16M | 0 | 0 | 0 |
Net receivables | 10.24B | 11.90B | 8.06B | 12.03B | 6.15B | 0 | 3.50B | 4.81B | 0 | 0 |
Inventory | 16.43B | 16.09B | 14.86B | 11.87B | 9.67B | 7.33B | 5.77B | 3.82B | 2.58B | 2.19B |
Other current assets | 2.89B | -100K | -100K | 200K | 1.76B | 9.94B | 1.40B | 0 | 3.81B | 3.16B |
Total current assets | 30.78B | 28.60B | 25.77B | 24.62B | 19.57B | 18.24B | 15.06B | 8.90B | 6.87B | 5.41B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 30.71B | 39.47B | 36.48B | 30.99B | 24.39B | 18.37B | 8.23B | 5.94B | 3.26B | 2.98B |
Goodwill | 0 | 0 | 0 | 0 | 36M | 37.7M | 435.58M | 352.80M | 0 | 0 |
Intangible assets | 0 | 1.54B | 3.22B | 2.99B | 2.66B | 1.61B | 0 | 0 | 0 | 0 |
Long term investments | 930.2M | 1.18B | 493.1M | 176.2M | 487.6M | 294.6M | 867.3M | 22.64M | 0 | 0 |
Other non-current assets | 2.02B | 348.8M | -100K | -100K | 467.3M | 711.4M | -250.26M | 1.20B | 382.91M | 32.61M |
Total non-current assets | 33.67B | 42.61B | 41.31B | 35.26B | 28.20B | 21.16B | 9.52B | 7.50B | 3.64B | 3.01B |
Total assets | 64.45B | 71.22B | 67.08B | 59.89B | 47.77B | 39.41B | 24.59B | 16.41B | 10.51B | 8.43B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 3.65B | 2.99B | 2.13B | 8.34B | 94.7M | 6.10B | 4.38B | 0 | 0 |
Short term debt | 4.50B | 6.44B | 3.12B | 8.70B | 6.29B | 1.77B | 1.56B | 2.44B | 1.39B | 0 |
Total current liabilities | 14.55B | 17.16B | 12.80B | 17.51B | 14.89B | 11.23B | 7.67B | 6.84B | 5.34B | 2.13B |
| Non-current liabilities: | ||||||||||
Long term debt | 628.8M | 721.4M | 2.71B | 9.60B | 4.99B | 5B | 0 | 188M | 948.56M | 3.27B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 53.74M |
Other non-current liabilities | 1.09B | 958.1M | 100K | 100K | 200K | 354.5M | 914.09M | 128.43M | 176.81M | 14.50M |
Total non-current liabilities | 1.72B | 1.67B | 3.61B | 10.47B | 5.70B | 5.97B | 914.09M | 724.38M | 1.22B | 3.34B |
Total liabilities | 16.27B | 18.84B | 16.42B | 27.98B | 20.59B | 17.20B | 8.58B | 7.56B | 6.56B | 5.48B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |